Skip to main content

Carbamazepine (International)

In the US, Carbamazepine (carbamazepine systemic) is a member of the drug class dibenzazepine anticonvulsants and is used to treat Bipolar Disorder, Borderline Personality Disorder, Cluster-Tic Syndrome, Cyclothymic Disorder, Diabetic Peripheral Neuropathy, Dystonia, Epilepsy, Occipital Neuralgia, Peripheral Neuropathy, Reflex Sympathetic Dystrophy Syndrome, Schizoaffective Disorder, Seizures, Trigeminal Neuralgia and Vulvodynia.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N03AF01

CAS registry number (Chemical Abstracts Service)

0000298-46-4

Chemical Formula

C15-H12-N2-O

Molecular Weight

236

Therapeutic Category

Antiepileptic agent

Chemical Name

5H-Dibenz[b,f]azepine-5-carboxamide

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs